Clinical Research on biomarkers

Clinical Research

The Biomarkers discover is major important application in the field of cancer innovations through Biomarker meetings.  Bioethics is a protected innovation which makes to increase the standard of theory regarding clinical approval of biomarkers. Right now use of biomarkers is blasting business. A large portion of the developed associations like Parexel, pfizer and Quintiles are into clinical innovative work. Different types of reporting bias and publication bias, make the association between CRP and prognosis among patients with stable coronary disease one of the most emerging iinovative work by using prognostic biomarker. Publication bias, statistical analytic protocols and registration of studies are one of other measures which might help increase the quality of prognostic biomarker research